noscript

News and Announcements

OncoSil Medical Recruits Second Subject at Monash Health Melbourne for Global Pancreatic Clinical Study Programme

  • Published May 11, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

OncoSil Medical Limited (ASX: OSL) a medical device company focused on localised treatments for patients with pancreatic and liver cancer, is pleased to announce that Monash Health has recruited the second subject for its global clinical study program in pancreatic cancer. The second subject has completed all baseline assessments, and will now commence one month of chemotherapy prior to implantation with the OncoSil™ device.

KEY TAKEAWAYS:

  • Secondsubjectrecruited for global clinical study in pancreatic cancer by MonashHealth, Melbourne
  • This subject is the second in a total of 20 subjects required to meet the Supplemental data request to secure CE Marking
  • First subject implanted with the OncoSil™ device on April 24 at Monash Health, Melbourne

OncoSil Chief Medical Officer Dr Ashish Soman commented: “We are pleased with the recruitment efforts and engagement to date by MonashHealth as our lead Australian trial site, and continue to work closely with their team to progress additional patient recruitment for this important global study.”

OncoSil Medical is a medical device company seeking to advance radiation for cancer patients.

Request Information

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now